A nanocarrier platform for targeted therapies
Nanomedx has developed a universal nanocarrier platform that enables delivery of biointeractive cargo across a range of biomedical and therapeutic applications.
One platform, multiple applications
A single core technology, more than one use case
Nanomedx's nanoparticle carrier platform adapts across clinical applications.
Pipeline
Placeholder we may want in the future
Some text goes here
Research
Preclinical
Clinical / Pilot
Regulatory
GMP & Market
Core platform
Preclinical
Peripheral Artery Disease (NanoHeal Device)
Preclinical
Richard Valves
Research
Placeholder Section
Placeholder Section
Placeholder Section
Placeholder 1
Placeholder decscription
Placeholder 2
Placeholder decscription
Placeholder 3
Placeholder decscription
Placeholder 4
Placeholder decscription
Leadership & Team
Leadership
Bede O'Connor
CEO
Placeholder bio
Prof. Steven Wise
Co-Founder & CSO
Placeholder bio
Team
Dr. Timothy Mitchell
Lead Engineer
Placeholder bio
Danyon Munro
Placeholder Role
Placeholder bio
Dr. Richard Tan
Co-Founder, Placeholder Role
Placeholder bio
Chien Hung
Co-Founder, Placeholder Role
Placeholder bio
In partnership with
The University of SydneyMTPConnect